Clinical Pharmacodynamics of Cannabinoids

REFERENCES

• Abadji , V. , Lin , S. , Gihan , T. , Griffen , G. , Stevenson , L. A. , Pertwee , G. R. and Makriyannis , A. 1994 . (R)-methanandamide: A chiral novel anandamide possessing higher potency and metabolic stability. . J Med Chem , 37 : 1889 – 93 .
   PubMed Web of Science ®Google Scholar
• Abood , M. E. , Sauss , C. , Fan , F. , Tilton , C. L. and Martin , B. R. 1993 . Development of behavioral tolerance to delta 9-THC without alteration of cannabinoid receptor binding or mRNA levels in whole brain. . Pharmacol Biochem Behav , 46 ( 3 ) : 575 – 9 .
   PubMed Web of Science ®Google Scholar
• Abrahamov , A. and Mechoulam , R. 1995 . An efficient new cannabinoid antiemetic in pediatric oncology. . Life Sci , 56 ( 23–24 ) : 2097 – 102 .
   PubMed Web of Science ®Google Scholar
• Abrams , D. I. , Leiser , R. J. , Hilton , J. F. , Shade , S. B. , Elbeik , T. A. , Aweeka , F. A. , Aberg , J. A. , Benowitz , L. N. , Bredt , B. M. , Deeks , S. G. , Kosel , B. W. , McCune , J. M. , Mitchell , T. F. , Mulligan , K. and Schambelan , M. 2001 . “ Short-term effects of cannabinoids in patients with HIV infection. ” . In 2001 Congress on Cannabis and the Cannabinoids 7 Cologne, , Germany : International Asociation for Cannabis as Medicine .
   Google Scholar
• Adami , M. , Frati , P. , Bertini , S. , Kulkarni-Narla , A. , Brown , D. R. , de Caro , G. , Coruzzi , G. and Soldani , G. 2002 . Gastric antisecretory role and immunohistochemical localization of cannabinoid receptors in the rat stomach. . Br J Pharmacol , 135 ( 7 ) : 1598 – 606 .
   PubMed Web of Science ®Google Scholar
• Adams , I. B. and Martin , B. R. 1996 . Cannabis: pharmacology and toxicology in animals and humans. . Addiction , 91 ( 11 ) : 1585 – 614 .
   PubMed Web of Science ®Google Scholar
• Agurell , S. , Carlsson , S. , Lindgren , J. E. , Ohlsson , A. , Gillespie , H. and Hollister , L. 1981 . Interactions of delta 1-tetrahydrocannabinol with cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentography. . Experientia , 37 ( 10 ) : 1090 – 2 .
   PubMedGoogle Scholar
• Anthony , J. C. , Warner , L. A. and Kessler , R. C. 1994 . Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: basic findings from the National Comorbidity Survey. . Experimental and Clin Psychopharmacol , 2 : 244 – 68 .
   Web of Science ®Google Scholar
• Archer , R. A. , Stark , P. and Lemberger , L. 1986 . “ Nabilone. In ” . In Cannabinoids as therapeutic agents. Edited by: Mechoulam , R. 85 – 103 . Boca Raton : CRC Press .
   Google Scholar
• Arevalo-Martin , A. , Vela , J. M. , Molina-Holgado , E. , Borrell , J. and Guaza , C. 2003 . Therapeutic action of cannabinoids in a murine model of multiple sclerosis. . J Neurosci , 23 ( 7 ) : 2511 – 6 .
   PubMed Web of Science ®Google Scholar
• Bachs , L. and Morland , H. 2001 . Acute cardiovascular fatalities following cannabis use. . Forensic Sci Int , 124 ( 2–3 ) : 200 – 3 .
   PubMed Web of Science ®Google Scholar
• Baek , S. H. , Kim , Y. O. , Kwag , J. S. , Choi , K. E. , Jung , W. Y. and Han , D. S. 1998 . Boron trifluoride etherate on silica-A modified Lewis acid reagent (VII). Antitumor activity of cannabigerol against human oral epitheloid carcinoma cells. . Arch Pharm Res , 21 ( 3 ) : 353 – 6 .
   PubMed Web of Science ®Google Scholar
• Baker , D. , Pryce , G. , Croxford , J. L. , Brown , P. , Pertwee , R. G. , Makriyannis , A. , Khanolkar , A. , Layward , L. , Fezza , F. , Bisogno , T. and Di Marzo , V. 2001 . Endocannabinoids control spasticity in a multiple sclerosis model. . FASEB J , 15 ( 2 ) : 300 – 2 .
   PubMed Web of Science ®Google Scholar
• Barann , M. , Molderings , G. , Bruss , M. , Bonisch , H. , Urban , B. W. and Gothert , M. 2002 . Direct inhibition by cannabinoids of human 5-HT3A receptors: probable involvement of an allosteric modulatory site. . Br J Pharmacol , 137 ( 5 ) : 589 – 96 .
   PubMed Web of Science ®Google Scholar
• Bass , C. E. and Martin , B. R. 2000 . Time course for the induction and maintenance of tolerance to δ9-tetrahydrocannabinol in mice. . Drug Alcohol Depend , 60 ( 2 ) : 113 – 9 .
   PubMed Web of Science ®Google Scholar
• Beal , J. E. , Olson , R. , Laubenstein , L. , Morales , J. O. , Bellman , P. , Yangco , B. , Lefkowitz , L. , Plasse , TF and Shepard , KV . 1995 . Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. . J Pain Symptom Manage , 10 ( 2 ) : 89 – 97 .
   PubMed Web of Science ®Google Scholar
• Beal , J. E. , Olson , R. , Lefkowitz , L. , Laubenstein , L. , Bellman , P. , Yangco , B. , Morales , J. O. , Murphy , R. , Powderly , W. , Plasse , T. F. , Mosdell , K. W. and Shepard , K. V. 1997 . Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia. . J Pain Symptom Manage , 14 ( 1 ) : 7 – 14 .
   PubMed Web of Science ®Google Scholar
• Beaulieu , P. , Bisogno , T. , Punwar , S. , Farquhar-Smith , W. P. , Ambrosino , G. , Di Marzo , V. and Rice , A. S. 2000 . Role of the endogenous cannabinoid system in the formalin test of persistent pain in the rat. . Eur J Pharmacol , 396 ( 2–3 ) : 85 – 92 .
   PubMedGoogle Scholar
• Beltramo , M. , Stella , N. , Calignano , A. , Lin , S. Y. , Makriyannis , A. and Piomelli , D. 1997 . Functional role of high-affinity anandamide transport, as revealed by selective inhibition. . Science , 277 ( 5329 ) : 1094 – 7 .
   PubMed Web of Science ®Google Scholar
• Benowitz , N. L. and Jones , R. T. 1975 . Cardiovascular effects of prolonged delta-9-tetrahydrocannabinol ingestion. . Clin Pharmacol Ther , 18 ( 3 ) : 287 – 97 .
   PubMed Web of Science ®Google Scholar
• Bisogno , T. , Hanus , L. , De Petrocellis , L. , Tchilibon , S. , Ponde , D. E. , Brandi , I. , Moriello , A. S. , Davis , J. B. , Mechoulam , R. and Di Marzo , V. 2001 . Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. . Br J Pharmacol , 134 ( 4 ) : 845 – 52 .
   PubMed Web of Science ®Google Scholar
• Blazquez , C. , Casanova , M. L. , Planas , A. , Del Pulgar , T. G. , Villanueva , C. , Fernandez-Acenero , M. J. , Aragones , J. , Huffman , J. W. , Jorcano , J. L. and Guzman , M. 2003 . Inhibition of tumor angiogenesis by cannabinoids. . FASEB J , 17 ( 3 ) : 529 – 31 .
   PubMed Web of Science ®Google Scholar
• Bonz , A. , Laser , M. , Kullmer , S. , Kniesch , S. , Babin-Ebell , J. , Popp , V. , Ertl , G. and Wagner , J. A. 2003 . Cannabinoids acting on CB1 receptors decrease contractile performance in human atrial muscle. . J Cardiovasc Pharmacol , 41 ( 4 ) : 657 – 64 .
   PubMed Web of Science ®Google Scholar
• Bornheim , L. M. and Grillo , M. P. 1998 . Characterization of cytochrome P450 3A in-activation by cannabidiol: possible involvement of cannabidiol-hydroxyquinone as a P450 inactivator. . Chem Res Toxicol , 11 ( 10 ) : 1209 – 16 .
   PubMed Web of Science ®Google Scholar
• Bornheim , L. M. , Kim , K. Y. , Li , J. , Perotti , B. Y. and Benet , L. Z. 1995 . Effect of cannabidiol pretreatment on the kinetics of tetrahydrocannabinol metabolites in mouse brain. . Drug Metab Dispos , 23 ( 8 ) : 825 – 31 .
   PubMed Web of Science ®Google Scholar
• Braida , D. , Pozzi , M. , Cavallini , R. and Sala , M. 2001 . Conditioned place preference induced by the cannabinoid agonist CP 55,940: interaction with the opioid system. . Neuroscience , 104 ( 4 ) : 923 – 6 .
   PubMed Web of Science ®Google Scholar
• Breivogel , C. S. , Griffin , G. , Di Marzo , V. and Martin , B. R. 2001 . Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. . Mol Pharmacol , 60 ( 1 ) : 155 – 63 .
   PubMed Web of Science ®Google Scholar
• Brenneisen , R. , Egli , A. , Elsohly , M. A. , Henn , V. and Spiess , Y. 1996 . The effect of orally and rectally administered delta 9-tetrahydrocannabinol on spasticity: a pilot study with 2 patients. . Int J Clin Pharmacol Ther , 34 ( 10 ) : 446 – 52 .
   PubMed Web of Science ®Google Scholar
• British Medical Association. 1997 . Therapeutic uses of cannabis Amsterdam : Harwood Academic Publishers. .
   Google Scholar
• Brody , S. and Preut , R. 2002 . Cannabis, tobacco, and caffeine use modify the blood pressure reactivity protection of ascorbic acid. . Pharmacol Biochem Behav , 72 ( 4 ) : 811 – 6 .
   PubMed Web of Science ®Google Scholar
• Bueb , J. L. , Lambert , D. M. and Tschirhart , E. J. 2001 . Receptor-independent effects of natural cannabinoids in rat peritoneal mast cells in vitro. . Biochim Biophys Acta , 1538 ( 2–3 ) : 252 – 9 .
   PubMedGoogle Scholar
• Burstein , S. 2002 . “ Therapeutic potential of ajulemic acid (CT3). In ” . In Cannabis and cannabinoids. Pharmacology, toxicology, and therapeutic potential Edited by: Grotenhermen , F. and Russo , E. 381 – 8 . New York : The Haworth Press .
   Google Scholar
• Burstein , S. , Hunter , S. A. , Latham , V. and Renzulli , L. 1987 . A major metabolite of delta 1-tetrahydrocannabinol reduces its cataleptic effect in mice. . Experientia , 43 ( 4 ) : 402 – 3 .
   PubMedGoogle Scholar
• Burstein , S. H. 1999 . The cannabinoid acids: nonpsychoactive derivatives with therapeutic potential. . Pharmacol Ther , 82 ( 1 ) : 87 – 96 .
   PubMed Web of Science ®Google Scholar
• Burstein , S. H. , Audette , C. A. , Doyle , S. A. , Hull , K. , Hunter , S. A. and Latham , V. 1989 . Antagonism to the actions of platelet activating factor by a nonpsychoactive cannabinoid. . J Pharmacol Exp Ther , 251 ( 2 ) : 531 – 5 .
   PubMed Web of Science ®Google Scholar
• Cabral , G. 2002 . “ Immune system. In ” . In Cannabis and cannabinoids. Pharmacology, toxicology, and therapeutic potential Edited by: Grotenhermen , F. and Russo , E. 279 – 88 . New York : The Haworth Press .
   Google Scholar
• Calhoun , S. R. , Galloway , G. P. and Smith , D. E. 1998 . Abuse potential of dronabinol (Marinol®). . J Psychoactive Drugs , 30 ( 2 ) : 187 – 96 .
   PubMed Web of Science ®Google Scholar
• Calignano , A. , Katona , I. , Desarnaud , F. , Giuffrida , A. , La Rana , G. , Mackie , K. , Freund , T. F. and Piomelli , D. 2000 . Bidirectional control of airway responsiveness by endogenous cannabinoids. . Nature , 408 ( 6808 ) : 96 – 101 .
   PubMed Web of Science ®Google Scholar
• Carley , D. W. , Paviovic , S. , Janelidze , M. and Radulovacki , M. 2002 . Functional role for cannabinoids in respiratory stability during sleep. . Sleep , 25 ( 4 ) : 391 – 8 .
   PubMed Web of Science ®Google Scholar
• Casanova , M. L. , Blazquez , C. , Martinez-Palacio , J. , Villanueva , C. , Fernandez-Acenero , M. J. , Huffman , J. W. , Jorcano , J. L. and Guzman , M. 2003 . Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. . J Clin Invest , 111 ( 1 ) : 43 – 50 .
   PubMed Web of Science ®Google Scholar
• Chan , P. C. , Sills , R. C. , Braun , A. G. , Haseman , J. K. and Bucher , J. R. 1996 . Toxicity and carcinogenicity of delta 9-tetrahydrocannabinol in Fischer rats and B6C3F1 mice. . Fundam Appl Toxicol , 30 ( 1 ) : 109 – 117 .
   PubMedGoogle Scholar
• Chang , M. C. , Berkery , D. , Schuel , R. , Laychock , S. G. , Zimmerman , A. M. , Zimmerman , S. and Schuel , H. 1993 . Evidence for a cannabinoid receptor in sea urchin sperm and its role in blockade of the acrosome reaction. . Mol Reprod Dev , 36 ( 4 ) : 507 – 16 .
   PubMed Web of Science ®Google Scholar
• Chapman , V. 1999 . The cannabinoid CB1 receptor antagonist, SR141716A, selectively facilitates nociceptive responses of dorsal horn neurones in the rat. . Br J Pharmacol , 127 ( 8 ) : 1765 – 7 .
   PubMed Web of Science ®Google Scholar
• Cichewicz , D. L. and McCarthy , E. A. 2003 . Antinociceptive synergy between D9-tetrahydrocannabinol and opioids after oral administration. . J Pharmacol Exp Ther , 304 ( 3 ) : 1010 – 5 .
   PubMed Web of Science ®Google Scholar
• Cichewicz , D. L. and Welch , S. P. 2003 . Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral δ9-THC. . J Pharmacol Exp Ther , [epub ahead of print]
   Google Scholar
• Citron , M. L. , Herman , T. S. , Vreeland , F. , Krasnow , S. H. and Fossieck , B. E. Jr. 1985 . Antiemetic efficacy of levonantradol compared to delta-9-tetrahydrocannabinol for chemotherapy-induced nausea and vomiting. . Cancer Treat Rep , 69 : 109 – 12 .
   PubMedGoogle Scholar
• Clermont-Gnamien , S. , Atlani , S. , Attal , N. , Le Mercier , F. , Guirimand , F. and Brasseur , L. 2002 . [The therapeutic use of D9-tetrahydrocannabinol (dronabinol) in refractory neuropathic pain] [Article in French]. . Presse Med , 31 ( 39 Pt 1 ) : 1840 – 5 .
   PubMed Web of Science ®Google Scholar
• Clifford , D. B. 1983 . Tetrahydrocannabinol for tremor in multiple sclerosis. . Ann Neurol , 13 ( 6 ) : 669 – 71 .
   PubMed Web of Science ®Google Scholar
• Colasanti , B. K. 1990 . A comparison of the ocular and central effects of delta 9-tetrahydrocannabinol and cannabigerol. . J Ocul Pharmacol , 6 ( 4 ) : 259 – 69 .
   PubMedGoogle Scholar
• Colasanti , B. K. , Brown , R. E. and Craig , C. R. 1984 . Ocular hypotension, ocular toxicity, and neurotoxicity in response to marihuana extract and cannabidiol. . Gen Pharmacol , 15 ( 6 ) : 479 – 84 .
   PubMedGoogle Scholar
• Consroe , P. , Sandyk , R. and Snider , S. R. 1986 . Open label evaluation of cannabidiol in dystonic movement disorders. . Int J Neurosci , 30 ( 4 ) : 277 – 82 .
   PubMed Web of Science ®Google Scholar
• Coruzzi , G. , Adami , M. , Coppelli , G. , Frati , P. and Soldani , G. 1999 . Inhibitory effect of the cannabinoid receptor agonist WIN 55,212–2 on pentagastrin-induced gastric acid secretion in the anaesthetized rat. . Naunyn Schmiedebergs Arch Pharmacol , 360 ( 6 ) : 715 – 8 .
   PubMed Web of Science ®Google Scholar
• Costa , B. , Parolaro , D. and Colleoni , M. 1996 . Chronic cannabinoid, CP-55,940, administration alters biotransformation in the rat. . Eur J Pharmacol , 313 ( 1–2 ) : 17 – 24 .
   PubMedGoogle Scholar
• Costa , B. , Giagnoni , G. , Conti , S. , Parolaro , D. and Colleoni , M. 2003 . Cannabidiol is an oral effective therapeutic agent both in acute inflammation and in chronic FCA-induced arthritis. . First European Workshop on Cannabinoid Research. , Madrid (Spain)
   Google Scholar
• Cravatt , B. F. , Demarest , K. , Patricelli , M. P. , Bracey , M. H. , Giang , D. K. , Martin , B. R. and Lichtman , A. H. 2001 . Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. . Proc Natl Acad Sci U S A , 98 ( 16 ) : 9371 – 6 .
   PubMed Web of Science ®Google Scholar
• Crawford , W. J. and Merritt , J. C. 1979 . Effects of tetrahydrocannabinol on arterial and intraocular hypertension. . Int J Clin Pharmacol Biopharm , 17 ( 5 ) : 191 – 6 .
   PubMedGoogle Scholar
• Croxford , J. L. and Miller , S. D. 2003 . Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R(+)WIN55,212. . J Clin Invest , 111 ( 8 ) : 1231 – 40 .
   PubMed Web of Science ®Google Scholar
• Dansak , D. A. 1997 . “ As an antiemetic and appetite stimulant in cancer patients. In ” . In Cannabis in medical practice: A legal, historical and pharmacological overview of the therapeutic use of marijuana Edited by: Mathre , M. L. 69 – 83 . Jefferson, NC : McFarland and Co .
   Google Scholar
• Dansak , D. A. 1997 . “ As an antiemetic and appetite stimulant in cancer patients. In ” . In Cannabis in medical practice: A legal, historical and pharmacological overview of the therapeutic use of marijuana Edited by: Mathre , M. L. 69 – 83 . Jefferson, NC : McFarland and Co .
   Google Scholar
• Darmani , N. A. 2001 . Delta-9-tetrahydrocannabinol differentially suppresses cisplatin-induced emesis and indices of motor function via cannabinoid CB(1) receptors in the least shrew. . Pharmacol Biochem Behav , 69 ( 1–2 ) : 239 – 49 .
   PubMedGoogle Scholar
• Davis , J. P. and Ramsey , H. H. 1949 . Antiepileptic action of marijuana active substances. . Fed Proc , 8 : 284
   Google Scholar
• De Petrocellis , L. , Melck , D. , Palmisano , A. , Bisogno , T. , Laezza , C. , Bifulco , M. and Di Marzo , V. 1998 . The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. . Proc Natl Acad Sci U S A , 95 ( 14 ) : 8375 – 80 .
   PubMed Web of Science ®Google Scholar
• De Petrocellis , L. , Melck , D. , Bisogno , T. , Milone , A. and Di Marzo , V. 1999 . Finding of the endocannabinoid signalling system in Hydra, a very primitive organism: possible role in the feeding response. . Neuroscience , 92 ( 1 ) : 377 – 87 .
   PubMed Web of Science ®Google Scholar
• De Petrocellis , L. , Melck , D. , Bisogno , T. and Di Marzo , V. 2000 . Endocannabinoids and fatty acid amides in cancer, inflammation and related disorders. . Chem Phys Lipids , 108 ( 1–2 ) : 191 – 209 .
   PubMed Web of Science ®Google Scholar
• Devane , W. A. , Dysarz , F. A. 3d , Johnson , M. R. , Melvin , L. S. and Howlett , A. C. 1988 . Determination and characterization of a cannabinoid receptor in rat brain. . Mol Pharmacol , 34 ( 5 ) : 605 – 13 .
   PubMed Web of Science ®Google Scholar
• Devane , W. A. , Hanus , L. , Breuer , A. , Pertwee , R. G. , Stevenson , L. A. , Griffin , G. , Gibson , D. , Mandelbaum , A. , Etinger , A. and Mechoulam , R. 1992 . Isolation and structure of a brain constituent that binds to the cannabinoid receptor. . Science , 258 ( 5090 ) : 1946 – 9 .
   PubMed Web of Science ®Google Scholar
• Dewey , W. L. 1986 . Cannabinoid pharmacology. . Pharmacol Rev , 38 ( 2 ) : 151 – 78 .
   PubMed Web of Science ®Google Scholar
• Di Marzo , V. 1998 . ‘Endocannabinoids’ and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance. . Biochim Biophys Acta , 1392 ( 2–3 ) : 153 – 75 .
   PubMedGoogle Scholar
• Di Marzo , V. , Breivogel , C. S. , Tao , Q. , Bridgen , D. T. , Razdan , R. K. , Zimmer , A. M. , Zimmer , A. and Martin , B. R. 2000 . Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain. . J Neurochem , 75 ( 6 ) : 2434 – 44 .
   PubMed Web of Science ®Google Scholar
• Di Marzo , V. , Berrendero , F. , Bisogno , T. , Gonzalez , S. , Cavaliere , P. , Romero , J. , Cebeira , M. , Ramos , J. A. and Fernandez-Ruiz , J. J. 2000 . Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of δ9-tetrahydrocannabinol-tolerant rats. . J Neurochem , 74 ( 4 ) : 1627 – 35 .
   PubMed Web of Science ®Google Scholar
• Di Marzo , V. , Griffin , G. , De Petrocellis , L. , Brandi , I. , Bisogno , T. , Williams , W. , Grier , M. C. , Kulasegram , S. , Mahadevan , A. , Razdan , R. K. and Martin , B. R. 2002 . A structure/activity relationship study on arvanil, an endocannabinoid and vanilloid hybrid. . J Pharmacol Exp Ther , 300 ( 3 ) : 984 – 91 .
   PubMed Web of Science ®Google Scholar
• Di Marzo , V. , Hill , M. P. , Bisogno , T. , Crossman , A. R. and Brotchie , J. M. 2000b . Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease. . FASEB J , 14 ( 10 ) : 1432 – 8 .
   PubMed Web of Science ®Google Scholar
• Di Marzo , V. , Goparaju , S. K. , Wang , L. , Liu , J. , Batkai , S. , Jarai , Z. , Fezza , F. , Miura , G. I. , Palmiter , R. D. , Sugiura , T. and Kunos , G. 2001 . Leptin-regulated endocannabinoids are involved in maintaining food intake. . Nature , 410 ( 6830 ) : 822 – 5 .
   PubMed Web of Science ®Google Scholar
• Domino , E. F. 1999 . “ Cannabinoids and the cholinergic system. In ” . In Marihuana and medicine Edited by: Nahas , G. , Sutin , K. M. , Harvey , D. J. and Agurell , S. 223 – 6 . Totowa, NJ : Humana Press .
   Google Scholar
• Doyle , S. A. , Burstein , S. H. , Dewey , W. L. and Welch , S. P. 1990 . Further studies on the antinociceptive effects of delta 6-THC-7-oic acid. . Agents Actions , 31 ( 1–2 ) : 157 – 63 .
   PubMedGoogle Scholar
• Elsner , F. , Radbruch , L. and Sabatowski , R. 2001 . Tetrahydrocannabinol zur Therapie chronischer Schmerzen [Tetrahydrocannabinol for treatment of chronic pain]. . Schmerz , 15 ( 3 ) : 200 – 4 .
   PubMedGoogle Scholar
• ElSohly , M. A. 2002 . “ Chemical constituents of cannabis. In ” . In Cannabis and cannabinoids. Pharmacology, toxicology, and therapeutic potential Edited by: Grotenhermen , F. and Russo , E. 27 – 36 . New York : The Haworth Press .
   Google Scholar
• Evans , A. T. , Formukong , E. A. and Evans , F. J. 1987 . Actions of cannabis constituents on enzymes of arachidonate, metabolism: anti-inflammatory potential. . Biochem Pharmacol , 36 ( 12 ) : 2035 – 7 .
   PubMed Web of Science ®Google Scholar
• Facchinetti , F. , Del Giudice , E. , Furegato , S. , Passarotto , M. and Leon , A. 2003 . Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide. . Glia , 41 ( 2 ) : 161 – 8 .
   PubMed Web of Science ®Google Scholar
• Fan , P. 1995 . Cannabinoid agonists inhibit the activation of 5-HT3 receptors in rat nodose ganglion neurons. . J Neurophysiol , 73 ( 2 ) : 907 – 10 .
   PubMed Web of Science ®Google Scholar
• Fezza , F. , Bisogno , T. , Minassi , A. , Appendino , G. , Mechoulam , R. and Di Marzo , V. 2002 . Noladin ether, a putative novel endocannabinoid: inactivation mechanisms and a sensitive method for its quantification in rat tissues. . FEBS Lett , 513 ( 2–3 ) : 294 – 8 .
   PubMedGoogle Scholar
• Formukong , E. A. , Evans , A. T. and Evans , F. J. 1989 . The inhibitory effects of cannabinoids, the active constituents of Cannabis sativa L. on human and rabbit platelet aggregation . J Pharm Pharmacol , 41 ( 10 ) : 705 – 9 .
   PubMed Web of Science ®Google Scholar
• Fowler , C. J. and Jacobsson , S. O. 2002 . Cellular transport of anandamide, 2-arachido-noylglycerol and palmitoylethanolamide—targets for drug development? . Prostaglandins Leukot Essent Fatty Acids , 66 ( 2–3 ) : 193 – 200 .
   PubMedGoogle Scholar
• Fowler , C. W. 2003 . Biochemistry and pharmacology of fatty acid amide hydrolase, the enzyme responsible for the metabolism of anandamide and related N-acyl ethanolamines. . First European Workshop on Cannabinoid Research. , Madrid (Spain)
   Google Scholar
• Fox , S. H. , Kellett , M. , Moore , A. P. , Crossman , A. R. and Brotchie , J. M. 2002 . Randomised, double-blind, placebo-controlled trial to assess the potential of cannabinoid receptor stimulation in the treatment of dystonia. . Mov Disord , 17 ( 1 ) : 145 – 9 .
   PubMed Web of Science ®Google Scholar
• Freemon , F. R. 1972 . Effects of marihuana on sleeping states. . JAMA , 220 ( 10 ) : 1364 – 5 .
   PubMed Web of Science ®Google Scholar
• Fride , E. , Foox , A. , Rosenberg , E. , Faigenboim , M. , Cohen , V. , Barda , L. , Blau , H. and Mechoulam , R. 2003 . Milk intake and survival in newborn cannabinoid CB(1) receptor knockout mice: evidence for a “CB(3)” receptor. . Eur J Pharmacol , 461 ( 1 ) : 27 – 34 .
   PubMed Web of Science ®Google Scholar
• Fride , E. and Shohami , E. 2002 . The endocannabinoid system: function in survival of the embryo, the newborn and the neuron. . Neuroreport , 13 ( 15 ) : 1833 – 41 .
   PubMed Web of Science ®Google Scholar
• Fride , E. , Barg , J. , Levy , R. , Saya , D. , Heldman , E. , Mechoulam , R. and Vogel , Z. 1995 . Low doses of anandamides inhibit pharmacological effects of delta 9-tetrahydro-cannabinol. . J Pharmacol Exp Ther , 272 ( 2 ) : 699 – 707 .
   PubMed Web of Science ®Google Scholar
• Fried , P. A. , Watkinson , B. and Gray , R. 1998 . Differential effects on cognitive functioning in 9- to 12-year olds prenatally exposed to cigarettes and marihuana. . Neurotoxicol Teratol , 20 ( 3 ) : 293 – 306 .
   PubMed Web of Science ®Google Scholar
• Galiègue , S. , Mary , S. , Marchand , J. , Dussossoy , D. , Carrière , D. , Carayon , P. , Bouaboula , M. , Shire , D. , Le Fur , G. and Casellas , P. 1995 . Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. . Eur J Biochem , 232 : 54 – 61 .
   PubMedGoogle Scholar
• Galve-Roperh , I. , Sanchez , C. , Cortes , M. L. , del Pulgar , T. G. , Izquierdo , M. and Guzman , M. 2000 . Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. . Nat Med , 6 ( 3 ) : 313 – 9 .
   PubMed Web of Science ®Google Scholar
• Gaoni , Y. and Mechoulam , R. 1964 . Isolation, structure and partial synthesis of the active constituent of hashish. . J Am Chem Soc , 86 : 1646 – 7 .
   Web of Science ®Google Scholar
• Georgotas , A. and Zeidenberg , P. 1979 . Observations on the effects of four weeks of heavy marihuana smoking on group interaction and individual behavior. . Compr Psychiatry , 20 ( 5 ) : 427 – 32 .
   PubMed Web of Science ®Google Scholar
• Gilson , I. and Busalacchi , M. 1998 . Marijuana for intractable hiccups. . Lancet , 351 ( 9098 ) : 267
   PubMed Web of Science ®Google Scholar
• Giuffrida , A. , Beltramo , M. and Piomelli , D. 2001 . Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology. . J Pharmacol Exp Ther , 298 ( 1 ) : 7 – 14 .
   PubMed Web of Science ®Google Scholar
• Glaser , S. T. , Abumrad , N. A. , Fatade , F. , Kaczocha , M. , Studholme , K. M. and Deutsch , D. G. 2003 . Evidence against the presence of an anandamide transporter. . Proc Natl Acad Sci USA , 100 ( 7 ) : 4269 – 74 .
   PubMed Web of Science ®Google Scholar
• Glass , M. and Felder , C. C. 1997 . Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. . J Neurosci , 17 : 5327 – 33 .
   PubMed Web of Science ®Google Scholar
• Gordon , E. and Devinsky , O. 2001 . Alcohol and marijuana: effects on epilepsy and use by patients with epilepsy. . Epilepsia , 42 ( 10 ) : 1266 – 72 .
   PubMed Web of Science ®Google Scholar
• Green , K. , Kearse , E. C. and McIntyre , O. L. 2001 . Interaction between Delta-9-tetrahydrocannabinol and indomethacin. . Ophthalmic Res , 33 ( 4 ) : 217 – 20 .
   PubMed Web of Science ®Google Scholar
• Greenwald , M. K. and Stitzer , M. L. 2000 . Antinociceptive, subjective and behavioral effects of smoked marijuana in humans. . Drug Alcohol Depend , 59 ( 3 ) : 261 – 75 .
   PubMed Web of Science ®Google Scholar
• Grinspoon , L. and Bakalar , J. B. 1993 . Marihuana, the forbidden medicine. New Haven : Yale University Press. .
   Google Scholar
• Grinspoon , L. and Bakalar , J. B. 1998 . The use of cannabis as a mood stabilizer in bipolar disorder: anecdotal evidence and the need for clinical research. . J Psychoactive Drugs , 30 ( 2 ) : 171 – 7 .
   PubMed Web of Science ®Google Scholar
• Grotenhermen , F. 2002a . “ Review of therapeutic effects. In ” . In Cannabis and cannabinoids. Pharmacology, toxicology, and therapeutic potential Edited by: Grotenhermen , F. and Russo , E. 123 – 42 . New York : The Haworth Press .
   Google Scholar
• Grotenhermen , F. 2002b . “ Review of unwanted actions of Cannabis and THC. In ” . In Cannabis and cannabinoids. Pharmacology, toxicology, and therapeutic potential Edited by: Grotenhermen , F. and Russo , E. 233 – 48 . New York : The Haworth Press .
   Google Scholar
• Grotenhermen , F. 2002c . “ Effects of cannabis and the cannabinoids. In ” . In Cannabis and cannabinoids. Pharmacology, toxicology, and therapeutic potential Edited by: Grotenhermen , F. and Russo , E. 55 – 66 . New York : The Haworth Press .
   Google Scholar
• Grotenhermen , F. and Russo , E. 2002 . Cannabis and cannabinoids. Pharmacology, toxicology, and therapeutic potential. New York : The Haworth Press. .
   Google Scholar
• Grundy , R. I. 2002 . The therapeutic potential of the cannabinoids in neuroprotection. . Expert Opin Investig Drugs , 11 ( 10 ) : 1365 – 74 .
   PubMed Web of Science ®Google Scholar
• Guzman , M. , Sanchez , C. and Galve-Roperh , I. 2001 . Control of the cell survival/death decision by cannabinoids. . J Mol Med , 78 ( 11 ) : 613 – 25 .
   PubMed Web of Science ®Google Scholar
• Hall , W. , Solowij , N. and Lemon , J. 1994 . The health and psychological consequences of cannabis use. , Monograph Series No. 25. Canberra : Commonwealth Department of Human Services and Health .
   Google Scholar
• Hampson , A. 2002 . “ Cannabinoids as neuroprotectants against ischemia. In ” . In Cannabis and cannabinoids. Pharmacology, toxicology, and therapeutic potential Edited by: Grotenhermen , F. and Russo , E. 101 – 10 . New York : The Haworth Press .
   Google Scholar
• Hampson , R. E. and Deadwyler , S. A. 1999 . Cannabinoids, hippocampal function and memory. . Life Sci , 65 : 715 – 23 .
   PubMed Web of Science ®Google Scholar
• Haney , M. , Bisaga , A. and Foltin , R. W. 2003 . Interaction between naltrexone and oral THC in heavy marijuana smokers. . Psychopharmacology (Berl) , 166 ( 1 ) : 77 – 85 .
   PubMed Web of Science ®Google Scholar
• Hanus , L. , Abu-Lafi , S. , Fride , E. , Breuer , A. , Vogel , Z. , Shalev , D. E. , Kustanovich , I. and Mechoulam , R. 2001 . 2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor. . Proc Natl Acad Sci U S A , 98 ( 7 ) : 3662 – 5 .
   PubMed Web of Science ®Google Scholar
• Hart , C. L. , Ward , A. S. , Haney , M. , Comer , S. D. , Foltin , R. W. and Fischman , M. W. 2002 . Comparison of smoked marijuana and oral δ9-tetrahydrocannabinol in humans. . Psychopharmacology (Berl) , 164 ( 4 ) : 407 – 15 .
   PubMed Web of Science ®Google Scholar
• Hartley , J. P. , Nogrady , S. G. and Seaton , A. 1978 . Bronchodilator effect of delta1-tetrahydrocannabinol. . Br J Clin Pharmacol , 5 ( 6 ) : 523 – 5 .
   PubMed Web of Science ®Google Scholar
• Hembree , W. C. 3d , Nahas , G. G. , Zeidenberg , P. and Huang , H. F. 1978 . Changes in human spermatozoa associated with high dose marihuana smoking. . Adv Biosci , : 429 – 39 . 22–23
   PubMedGoogle Scholar
• Hemming , M. and Yellowlees , P. M. 1993 . Effective treatment of Tourette's syndrome with marijuana. . J Psychopharmacol , 7 : 389 – 91 .
   PubMed Web of Science ®Google Scholar
• Hepler , R. S. and Frank , I. R. 1971 . Marihuana smoking and intraocular pressure. . JAMA , 217 ( 10 ) : 1392
   PubMed Web of Science ®Google Scholar
• Hepler , R. S. and Petrus , R. J. 1976 . “ Experiences with administration of marihuana to glaucoma patients. In ” . In The therapeutic potential of marihuana Edited by: Cohen , S. and Stillman , R. C. 63 – 75 . New York : Plenum Medical Book .
   Google Scholar
• Heyser , C. J. , Hampson , R. E. and Deadwyler , S. A. 1993 . Effects of delta-9-tetra-hydrocannabinol on delayed match to sample performance in rats: alterations in short-term memory associated with changes in task specific firing of hippocampal cells. . J Pharmacol Exp Ther , 264 ( 1 ) : 294 – 307 .
   PubMed Web of Science ®Google Scholar
• Holdcroft , A. , Smith , M. , Jacklin , A. , Hodgson , H. , Smith , B. , Newton , M. and Evans , F. 1997 . Pain relief with oral cannabinoids in familial Mediterranean fever. . Anaesthesia , 52 ( 5 ) : 483 – 6 .
   PubMed Web of Science ®Google Scholar
• Hollister , L. E. 1986 . Health aspects of cannabis. . Pharmacological Reviews , 38 : 1 – 20 .
   PubMed Web of Science ®Google Scholar
• Hollister , L. E. 1999 . “ Interactions of marihuana and δ9-THC with other drugs. In ” . In Marihuana and medicine Edited by: Nahas , G. , Sutin , K. M. , Harvey , D. J. and Agurell , S. 273 – 7 . Totowa, NJ : Humana Press .
   Google Scholar
• House of Lords Select Committee on Science and Technology. 1998 . Cannabis. The scientific and medical evidence. London : The Stationery Office. .
   Google Scholar
• Howlett , A. C. 2002 . The cannabinoid receptors. . Prostaglandins Other Lipid Mediat , : 68 – 69 . 619–31
   Google Scholar
• Huang , S. M. , Bisogno , T. , Trevisani , M. , Al-Hayani , A. , De Petrocellis , L. , Fezza , F. , Tognetto , M. , Petros , T. J. , Krey , J. F. , Chu , C. J. , Miller , J. D. , Davies , S. N. , Geppetti , P. , Walker , J. M. and Di Marzo , V. 2002 . An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. . Proc Natl Acad Sci U S A , 99 ( 12 ) : 8400 – 5 .
   PubMed Web of Science ®Google Scholar
• Huestis , M. A. , Gorelick , D. A , Heishman , S. J. , Preston , K. L. , Nelson , R. A. , Moolchan , E. T. and Frank , R. A. 2001 . Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716. . Arch Gen Psychiatry , 58 ( 4 ) : 322 – 8 .
   PubMed Web of Science ®Google Scholar
• Hunt , C. A. , Jones , R. T. , Herning , R. I. and Bachman , J. 1981 . Evidence that cannabidiol does not significantly alter the pharmacokinetics of tetrahydrocannabinol in man. . J Pharmacokinet Biopharm , 9 ( 3 ) : 245 – 60 .
   PubMedGoogle Scholar
• Hunt , C. A. and Jones , R. T. 1980 . Tolerance and disposition of tetrahydrocannabinol in man. . J Pharmacol Exp Ther , 215 ( 1 ) : 35 – 44 .
   PubMed Web of Science ®Google Scholar
• Izzo , A. A. , Fezza , F. , Capasso , R. , Bisogno , T. , Pinto , L. , Iuvone , T. , Esposito , G. , Mascolo , N. , Di Marzo , V. and Capasso , F. 2001 . Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation. . Br J Pharmacol , 134 ( 3 ) : 563 – 70 .
   PubMed Web of Science ®Google Scholar
• Izzo , A. A. , Pinto , L. , Borrelli , F. , Capasso , R. , Mascolo , N. and Capasso , F. 2000 . Central and peripheral cannabinoid modulation of gastrointestinal transit in physiological states or during the diarrhoea induced by croton oil. . Br J Pharmacol , 129 ( 8 ) : 1627 – 32 .
   PubMed Web of Science ®Google Scholar
• Jacobsson , S. O. , Wallin , T. and Fowler , C. J. 2001 . Inhibition of rat C6 glioma cell proliferation by endogenous and synthetic cannabinoids. Relative involvement of cannabinoid and vanilloid receptors. . J Pharmacol Exp Ther , 299 ( 3 ) : 951 – 9 .
   PubMed Web of Science ®Google Scholar
• Jaeger , W. , Benet , L. Z. and Bornheim , L. M. 1996 . Inhibition of cyclosporine and tetrahydrocannabinol metabolism by cannabidiol in mouse and human microsomes. . Xenobiotica , 26 ( 3 ) : 275 – 84 .
   PubMed Web of Science ®Google Scholar
• Jaggar , S. I. , Hasnie , F. S. , Sellaturay , S. and Rice , A. S. 1998 . The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain. . Pain , 76 ( 1–2 ) : 189 – 99 .
   PubMedGoogle Scholar
• Jain , A. K. , Ryan , J. R. , McMahon , F. G. and Smith , G. 1981 . Evaluation of intramuscular levonantrodol and placebo in acute postoperative pain. . Journal of Clinical Pharmacology , 21 ( Suppl ) 320S-6S
   PubMedGoogle Scholar
• Jan , T. R. , Farraj , A. K. , Harkema , J. R. and Kaminski , N. E. 2003 . Attenuation of the ovalbumin-induced allergic airway response by cannabinoid treatment in A/J mice small star, filled. . Toxicol Appl Pharmacol , 188 ( 1 ) : 24 – 35 .
   PubMed Web of Science ®Google Scholar
• Jatoi , A. , Windschitl , H. E. , Loprinzi , C. L. , Sloan , J. A. , Dakhil , S. R. , Mailliard , J. A. , Pundaleeka , S. , Kardinal , C. G. , Fitch , T. R. , Krook , J. E. , Novotny , P. J. and Christensen , B. 2002 . Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study. . J Clin Oncol , 20 ( 2 ) : 567 – 73 .
   PubMed Web of Science ®Google Scholar
• Jones , R. T. , Benowitz , N. and Bachman , J. 1976 . Clinical studies of cannabis tolerance and dependence. . Ann N Y Acad Sci , 282 : 221 – 39 .
   PubMed Web of Science ®Google Scholar
• Joy , J. E. , Watson , S. J. and Benson , J. A. 1999 . Marijuana and medicine: Assessing the science base. Washington, DC : Institute of Medicine, National Academy Press. .
   Google Scholar
• Kalant , H. , Corrigal , W. , Hall , W. and Smart , R. 1999 . The health effects of cannabis. Toronto, , Canada : Centre for Addiction and Mental Health. .
   Google Scholar
• Karler , R. and Turkanis , S. A. 1981 . The cannabinoids as potential antiepileptics. . J Clin Pharmacol , 21 ( 8–9 Suppl ) 437S-48S
   Google Scholar
• Karler , R. and Turkanis , S. A. 1987 . Different cannabinoids exhibit different pharmacological and toxicological properties. . NIDA Res Monogr , 79 : 96 – 107 .
   PubMedGoogle Scholar
• Karniol , I. G. , Shirakawa , I. , Kasinski , N. , Pfeferman , A. and Carlini , E. A. 1974 . Cannabidiol interferes with the effects of delta 9-tetrahydrocannabinol in man. . Eur J Pharmacol , 28 ( 1 ) : 172 – 7 .
   PubMed Web of Science ®Google Scholar
• Kathuria , S. , Gaetani , S. , Fegley , D. , Valino , F. , Duranti , A. , Tontini , A. , Mor , M. , Tarzia , G. , La Rana , G. , Calignano , A. , Giustino , A. , Tattoli , M. , Palmery , M. , Cuomo , V. and Piomelli , D. 2003 . Modulation of anxiety through blockade of anandamide hydrolysis. . Nat Med , 9 ( 1 ) : 76 – 81 .
   PubMed Web of Science ®Google Scholar
• Kelly , T. H. , Foltin , R. W. , Emurian , C. S. and Fischman , M. W. 1993 . Performance-based testing for drugs of abuse: dose and time profiles of marijuana, amphetamine, alcohol, and diazepam. . J Anal Toxicol , 17 ( 5 ) : 264 – 72 .
   PubMed Web of Science ®Google Scholar
• Killestein , J. , Hoogervorst , E. L. , Reif , M. , Kalkers , N. F. , Van Loenen , A. C. , Staats , P. G. , Gorter , R. W. , Uitdehaag , B. M. and Polman , C. H. 2002 . Safety, tolerability, and efficacy of orally administered cannabinoids in MS. . Neurology , 58 ( 9 ) : 1404 – 7 .
   PubMed Web of Science ®Google Scholar
• Kleiber , D. , Soellner , R. and Tossmann , P. 1997 . Cannabiskonsum in der Bundesrepublik Deutschland: Entwicklungstendenzen, Konsummuster und Einflußfaktoren. Bonn : Federal Ministry of Health. .
   Google Scholar
• Knoller , N. , Levi , L. , Shoshan , I. , Reichenthal , E. , Razon , N. , Rappaport , Z. H. and Biegon , A. 2002 . Dexanabinol (HU-211) in the treatment of severe closed head injury: a randomized, placebo-controlled, phase II clinical trial. . Crit Care Med , 30 ( 3 ) : 548 – 54 .
   PubMed Web of Science ®Google Scholar
• Koe , B. K. , Milne , G. M. , Weissman , A. , Johnson , M. R. and Melvin , L. S. 1985 . Enhancement of brain [3H]flunitrazepam binding and analgesic activity of synthetic cannabimimetics. . Eur J Pharmacol , 109 ( 2 ) : 201 – 12 .
   PubMed Web of Science ®Google Scholar
• Kosel , B. W. , Aweeka , F. T. , Benowitz , N. L. , Shade , S. B. , Hilton , J. F. , Lizak , P. S. and Abrams , D. I. 2002 . The effects of cannabinoids on the pharmacokinetics of indinavir and nelfinavir. . AIDS , 16 ( 4 ) : 543 – 50 .
   PubMed Web of Science ®Google Scholar
• Laine , K. , Jarvinen , K. and Jarvinen , T. 2003 . Topically administered CB(2)-receptor agonist, JWH-133, does not decrease intraocular pressure (IOP) in normotensive rabbits. . Life Sci , 72 ( 7 ) : 837 – 42 .
   PubMed Web of Science ®Google Scholar
• Lake , K. D. , Compton , D. R. , Varga , K. , Martin , B. R. and Kunos , G. 1997 . Cannabinoid-induced hypotension and bradycardia in rats is mediated by CB1-like cannabinoid receptors. . J Pharmacol Exp Ther , 281 : 1030 – 37 .
   PubMed Web of Science ®Google Scholar
• Lancz , G. , Specter , S. and Brown , H. K. 2002 . Suppressive effect of delta-9-tetra-hydrocannabinol on herpes simplex virus infectivity in vitro. . Proc Soc Exp Biol Med X , 196 ( 4 ) : 401 – 4 .
   Google Scholar
• Lane , M. , Vogel , C. L. , Ferguson , J. , Krasnow , S. , Saiers , J. L. , Hamm , J. , Salva , K. , Wiernik , P. H. , Holroyde , C. P. Hammill , S. 1991 . Dronabinol and prochlorperazine in combination for treatment of cancer chemotherapy-induced nausea and vomiting. . J Pain Symptom Manage , 6 ( 6 ) : 352 – 9 .
   PubMed Web of Science ®Google Scholar
• Lemberger , L. , Crabtree , R. E. and Rowe , H. M. 1972 . 11-hydroxy-δ9-tetrahydrocannabinol: pharmacology, disposition, and metabolism of a major metabolite of marihuana in man. . Science , 177 ( 43 ) : 62 – 4 .
   PubMedGoogle Scholar
• Leweke , F. M. , Giuffrida , A. , Wurster , U. , Emrich , H. M. and Piomelli , D. 1999 . Elevated endogenous cannabinoids in schizophrenia. . Neuroreport , 10 ( 8 ) : 1665 – 9 .
   PubMed Web of Science ®Google Scholar
• Lichtman , A. H. , Sheikh , S. M. , Loh , H. H. and Martin , B. R. 2001 . Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice. . J Pharmacol Exp Ther , 298 ( 3 ) : 1007 – 14 .
   PubMed Web of Science ®Google Scholar
• Lissoni , P. , Resentini , M. , Mauri , R. , Esposti , D. , Esposti , G. , Rossi , D. , Legname , G. and Fraschini , F. 1986 . Effects of tetrahydrocannabinol on melatonin secretion in man. . Horm Metab Res , 18 ( 1 ) : 77 – 8 .
   PubMed Web of Science ®Google Scholar
• Little , P. J. , Compton , D. R. , Mechoulam , R. and Martin , B. 1989 . Stereochemical effects of 11-OH-δ8-THC-dimethylheptyl in mice and dogs. . Pharmacol Biochem Behav , 32 : 661 – 6 .
   PubMed Web of Science ®Google Scholar
• Liu , J. , Li , H. , Burstein , S. H. , Zurier , R. B. and Chen , J. D. 2003 . Activation and binding of peroxisome proliferator-activated receptor gamma by synthetic cannabinoid ajulemic acid. . Mol Pharmacol , 63 ( 5 ) : 983 – 92 .
   PubMed Web of Science ®Google Scholar
• Loewe , S. 1950 . Cannabiswirkstoffe und Pharmakologie der Cannabinole. . Archiv für Experimentelle Pathologie und Pharmakologie , 211 : 175 – 93 .
   Google Scholar
• Lorenz , R. 2002 . A casuistic rationale for the treatment of spastic and myocloni in a childhood neurodegenerative disease: neuronal ceroid lipofuscinosis of the type Jansky-Bielschowsky. . Neuroendocrinol Lett , 23 ( 5–6 ) : 387 – 90 .
   PubMedGoogle Scholar
• Lucraft , H. H. and Palmer , M. K. 1982 . Randomized clinical trial of levonantradol and chlorpromazine in the prevention of radiotherapy-indiced vomiting. . Clin Radiol , 33 ( 6 ) : 621 – 2 .
   PubMed Web of Science ®Google Scholar
• Luthra , Y. K. , Esber , H. J. , Lariviere , D. M. and Rosenkrantz , H. 1980 . Assessment of tolerance to immunosuppressive activity of delta 9-tetrahydrocannabinol in rats. . J Immunopharmacol , 2 ( 2 ) : 245 – 56 .
   PubMed Web of Science ®Google Scholar
• Lyketsos , C. G. , Garrett , E. , Liang , K. Y. and Anthony , J. C. 1999 . Cannabis use and cognitive decline in persons under 65 years of age. . Am J Epidemiol , 149 ( 9 ) : 794 – 800 .
   PubMed Web of Science ®Google Scholar
• Malfait , A. M. , Gallily , R. , Sumariwalla , P. F. , Malik , A. S. , Andreakos , E. , Mechoulam , R. and Feldmann , M. 2000 . The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. . Proc Natl Acad Sci USA , 97 ( 17 ) : 9561 – 6 .
   PubMed Web of Science ®Google Scholar
• Martyn , C. N. , Illis , L. S. and Thom , J. 1995 . Nabilone in the treatment of multiple sclerosis. . Lancet , 345 ( 8949 ) : 579
   PubMed Web of Science ®Google Scholar
• Mathre , M. L. 1997 . Cannabis in medical practice: A legal, historical and pharmacological overview of the therapeutic use of marijuana. Jefferson, NC : McFarland and Co. .
   Google Scholar
• Mattes , R. D. , Shaw , L. M. and Engelman , K. 1994 . Effects of cannabinoids (marijuana) on taste intensity and hedonic ratings and salivary flow of adults. . Chem Senses , 19 ( 2 ) : 125 – 40 .
   PubMed Web of Science ®Google Scholar
• Maurer , M. , Henn , V. , Dittrich , A. and Hofmann , A. 1990 . Delta-9-tetrahydrocanna-binol shows antispastic and analgesic effects in a single case double-blind trial. . Eur Arch Psychiatry Neurol Sci , 240 ( 1 ) : 1 – 4 .
   Google Scholar
• McCallum , R. W. , Soykan , I. , Sridhar , K. R. , Ricci , D. A. , Lange , R. C. and Plankey , M. W. 1999 . Delta-9-tetrahydrocannabinol delays the gastric emptying of solid food in humans: a double-blind, randomized study. . Aliment Pharmacol Ther , 13 ( 1 ) : 77 – 80 .
   PubMed Web of Science ®Google Scholar
• McPartland , J. M. and Russo , E. B. 2001 . Cannabis and cannabis extracts: Greater than the sum of their parts? . J Cannabis Ther , 1 ( 3/4 ) : 103 – 32 .
   Google Scholar
• Mechoulam , R. 2002 . Discovery of endocannabinoids and some random thoughts on their possible roles in neuroprotection and aggression. . Prostaglandins Leukot Essent Fatty Acids , 66 ( 2–3 ) : 93 – 9 .
   PubMed Web of Science ®Google Scholar
• Mechoulam , R. , Shohami , E. , Fride , E. and Bab , I. 2003 . The ubiquitous role of endocannabinoids in physiological processes: examples in neuroprotection, feeding and bone formation. . First European Workshop on Cannabinoid Research. , Madrid (Spain)
   Google Scholar
• Mechoulam , R. 1986 . Cannabinoids as therapeutic agents. Boca Raton : CRC Press. .
   Google Scholar
• Mechoulam , R. and Shohami , E. 2002 . “ HU-211: Cannabinoid Neuroprotective Agent. In ” . In Cannabis and cannabinoids. Pharmacology, toxicology, and therapeutic potential Edited by: Grotenhermen , F. and Russo , E. 389 – 400 . New York : The Haworth Press .
   Google Scholar
• Mechoulam , R. and Hanus , L. 2002 . Cannabidiol: an overview of some chemical and pharmacological aspects. Part I: chemical aspects. . Chem Phys Lipids , 121 ( 1–2 ) : 35 – 43 .
   PubMed Web of Science ®Google Scholar
• Mechoulam , R. , Hanus , L. and Fride , E. 1998 . Towards cannabinoid drugs—revisited. . Prog Med Chem , 35 : 199 – 243 .
   PubMedGoogle Scholar
• Mechoulam , R. , Ben-Shabat , S. , Hanus , L. , Ligumsky , M. , Kaminski , N. E. , Schatz , A. R. , Gopher , A. , Almog , S. , Martin , B. R. and Compton , D. R. 1995 . Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. . Biochem Pharmacol , 50 ( 1 ) : 83 – 90 .
   PubMed Web of Science ®Google Scholar
• Meinck , H. M. , Schonle , P. W. and Conrad , B. 1989 . Effect of cannabinoids on spasticity and ataxia in multiple sclerosis. . J Neurol , 236 ( 2 ) : 120 – 2 .
   PubMed Web of Science ®Google Scholar
• Melamede , R. 2002 . “ Possible mechanisms in autoimmune diseases. In ” . In Cannabis and cannabinoids. Pharmacology, toxicology, and therapeutic potential Edited by: Grotenhermen , F. and Russo , E. 111 – 22 . Binghamton, NY : Haworth Press .
   Google Scholar
• Melck , D. , De Petrocellis , L. , Orlando , P. , Bisogno , T. , Laezza , C. , Bifulco , M. and Di Marzo , V. 2000 . Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation. . Endocrinology , 141 ( 1 ) : 118 – 26 .
   PubMed Web of Science ®Google Scholar
• Melvin , L. S. , Milne , G. M. , Johnson , M. R. , Subramaniam , B. , Wilken , G. H. and Howlett , A. C. 1993 . Structure-activity relationships for cannabinoid receptor-binding and analgesic activity: studies of bicyclic cannabinoid analogs. . Mol Pharmacol , 44 ( 5 ) : 1008 – 15 .
   PubMed Web of Science ®Google Scholar
• Merritt , J. C. , Olsen , J. L. , Armstrong , J. R. and McKinnon , S. M. 1981 . Topical delta 9-tetrahydrocannabinol in hypertensive glaucomas. . J Pharm Pharmacol , 33 ( 1 ) : 40 – 1 .
   PubMed Web of Science ®Google Scholar
• Merritt , J. C. , Crawford , W. J. , Alexander , P. C. , Anduze , A. L. and Gelbart , S. S. 1980 . Effect of marihuana on intraocular and blood pressure in glaucoma. . Ophthalmology , 87 ( 3 ) : 222 – 8 .
   PubMed Web of Science ®Google Scholar
• Miczek , K. A. and Dixit , B. N. 1980 . Behavioral and biochemical effects of chronic delta 9-tetrahydrocannabinol in rats. . Psychopharmacology (Berl) , 67 ( 2 ) : 195 – 202 .
   PubMed Web of Science ®Google Scholar
• Mikuriya , T. H. 1970 . Cannabis substitution. An adjunctive therapeutic tool in the treatment of alcoholism. . Med Times , 98 ( 4 ) : 187 – 91 .
   PubMedGoogle Scholar
• Mittleman , M. A. , Lewis , R. A. , Maclure , M. , Sherwood , J. B. and Muller , J. E. 2001 . Triggering myocardial infarction by marijuana. . Circulation , 103 ( 23 ) : 2805 – 9 .
   PubMed Web of Science ®Google Scholar
• Moss , D. E. , Manderscheid , P. Z. , Montgomery , S. P. , Norman , A. B. and Sanberg , P. R. 1989 . Nicotine and cannabinoids as adjuncts to neuroleptics in the treatment of Tourette syndrome and other motor disorders. . Life Sci , 44 ( 21 ) : 1521 – 5 .
   PubMed Web of Science ®Google Scholar
• Müller-Vahl , K. R. , Kolbe , H. and Dengler , R. 1997 . Gilles de la Tourette-Syndrom. Einfluß von Nikotin, Alkohol und Marihuana auf die klinische Symptomatik [Gilles de la Tourette-Syndrom. Influence of nicotine, alcohol and marijuana on clinical symptoms] [published in German]. . Nervenarzt , 68 : 985 – 9 .
   PubMedGoogle Scholar
• Müller-Vahl , K. R. , Prevedel , H. , Theloe , K. , Kolbe , H. , Emrich , H. M. and Schneider , U. 2003a . Treatment of Tourette syndrome with delta-9-tetrahydrocannabinol (delta 9-THC): no influence on neuropsychological performance. . Neuropsychopharm-acology , 28 ( 2 ) : 384 – 8 .
   PubMedGoogle Scholar
• Müller-Vahl , K. R. , Schneider , U. , Koblenz , A. , Jobges , M. , Kolbe , H. , Daldrup , T. and Emrich , H. M. 2002 . Treatment of Tourette's syndrome with δ9-tetrahydrocannabinol (THC): a randomized crossover trial. . Pharmacopsychiatry , 35 ( 2 ) : 57 – 61 .
   PubMed Web of Science ®Google Scholar
• Müller-Vahl , K. R. , Schneider , U. and Emrich , H. M. 1999 . Nabilone increases choreatic movements in Huntington's disease. . Mov Disord , 14 ( 6 ) : 1038 – 40 .
   PubMedGoogle Scholar
• Müller-Vahl , K. R. , Schneider , U. , Kolbe , H. and Emrich , H. M. 1999 . Treatment of Tourette's syndrome with delta-9-tetrahydrocannabinol. . Am J Psychiatry , 156 ( 3 ) : 495
   PubMed Web of Science ®Google Scholar
• Müller-Vahl , K. R. , Schneider , U. , Prevedel , H. , Theloe , K. , Kolbe , H. , Daldrup , T. and Emrich , H. M. 2003b . δ9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial. . J Clin Psychiatry , 64 ( 4 ) : 459 – 65 .
   PubMed Web of Science ®Google Scholar
• Murphy , L. 2002 . “ Hormonal system and reproduction. In ” . In Cannabis and cannabinoids. Pharmacology, toxicology, and therapeutic potential Edited by: Grotenhermen , F. and Russo , E. 289 – 98 . New York : The Haworth Press .
   Google Scholar
• Musty , R. E. and Consroe , P. 2002 . “ Spastic disorders. In ” . In Cannabis and cannabinoids. Pharmacology, toxicology, and therapeutic potential Edited by: Grotenhermen , F. and Russo , E. 195 – 204 . New York : The Haworth Press .
   Google Scholar
• Navarro , M. , Carrera , M. R. , Fratta , W. , Valverde , O. , Cossu , G. , Fattore , L. , Chowen , J. A. , Gomez , R. , del Arco , I. , Villanua , M. A. , Maldonado , R. , Koob , G. F. and de Fonseca , F. R. 2001 . Functional interaction between opioid and cannabinoid receptors in drug self-administration. . J Neurosci , 21 ( 14 ) : 5344 – 50 .
   PubMed Web of Science ®Google Scholar
• Notcutt , W. , Price , M. , Miller , R. , Newport , S. , Sansom , C. and Simmonds , S. 2001a . “ Medicinal cannabis extracts in chronic pain: (2) comparison of two patients with back pain and sciatica. ” . In 2001 Congress on Cannabis and the Cannabinoids 25 Cologne, , Germany : International Association for Cannabis as Medicine .
   Google Scholar
• Notcutt , W. , Price , M. , Miller , R. , Newport , S. , Sansom , C. and Simmonds , S. 2001b . “ Medicinal cannabis extracts in chronic pain: (3) comparison of two patients with multiple sclerosis. ” . In 2001 Congress on Cannabis and the Cannabinoids 26 Cologne, , Germany : International Association for Cannabis as Medicine .
   Google Scholar
• Noyes , R. Jr. , Brunk , S. F. , Avery , D. A.H. and Canter , A. C. 1975a . The analgesic properties of delta-9-tetrahydrocannabinol and codeine. . Clin Pharmacol Ther , 18 ( 1 ) : 84 – 9 .
   PubMed Web of Science ®Google Scholar
• Noyes , R. Jr. , Brunk , S. F. , Baram , D. A. and Canter , A. 1975b . Analgesic effect of delta-9-tetrahydrocannabinol. . J Clin Pharmacol , 15 ( 2–3 ) : 139 – 43 .
   PubMed Web of Science ®Google Scholar
• Noyes , R. and Baram , D. A. 1974 . Cannabis analgesia. . Compreh Psychiatr , 15 : 531 – 5 .
   PubMed Web of Science ®Google Scholar
• Nunez , L. A. and Gurpegui , M. 2002 . Cannabis-induced psychosis: a cross-sectional comparison with acute schizophrenia. . Acta Psychiatr Scand , 105 ( 3 ) : 173 – 8 .
   PubMed Web of Science ®Google Scholar
• O'Leary , D. S. , Block , R. I. , Koeppel , J. A. , Flaum , M. , Schultz , S. K. , Andreasen , N. C. , Ponto , L. B. , Watkins , G. L. , Hurtig , R. R. and Hichwa , R. D. 2002 . Effects of smoking marijuana on brain perfusion and cognition. . Neuropsychopharmacology , 26 ( 6 ) : 802 – 16 .
   PubMed Web of Science ®Google Scholar
• Ottani , A. and Giuliani , D. 2001 . Hu 210: a potent tool for investigations of the cannabinoid system. . CNS Drug Rev , 7 ( 2 ) : 131 – 45 .
   PubMedGoogle Scholar
• Parker , L. A. , Mechoulam , R. and Schlievert , C. 2002 . Cannabidiol, a non-psychoactive component of cannabis and its synthetic dimethylheptyl homolog suppress nausea in an experimental model with rats. . Neuroreport , 13 ( 5 ) : 567 – 70 .
   PubMed Web of Science ®Google Scholar
• Parker , L. A. , Mechoulam , R. , Schlievert , C. , Abbott , L. , Fudge , M. L. and Burton , P. 2003 . Effects of cannabinoids on lithium-induced conditioned rejection reactions in a rat model of nausea. . Psychopharmacology (Berl) , 166 ( 2 ) : 156 – 62 .
   PubMed Web of Science ®Google Scholar
• Pate, D. Glaucoma and Cannabinoids . 2002 . Cannabis and cannabinoids. Pharmacology, toxicology, and therapeutic potential Edited by: Grotenhermen , F. and Russo , E. 215 – 24 . New York : The Haworth Press .
   Google Scholar
• Perez-Reyes , M. 1999 . “ The psychologic and physiologic effects of active cannabinoids. In ” . In Marihuana and medicine Edited by: Nahas , G. , Sutin , K. M. , Harvey , D. J. and Agurell , S. 245 – 52 . Totowa, NJ : Humana Press .
   Google Scholar
• Perez-Reyes , M. , Simmons , J. , Brine , D. , Kimmel , G. L. , Davis , K. H. and Wall , M. E. 1976 . “ Rate of penetration of δ9-tetrahydrocannabinol and 11-hydroxy-δ9-tetra-hydrocannabinol to the brain of mice. In ” . In Marihuana: chemistry, biochemistry, and cellular effects Edited by: Nahas , G. G. 179 – 85 . New York : Springer .
   Google Scholar
• Perez-Reyes , M. , Timmons , M. , Lipton , M. , Davis , K. and Wall , M. 1972 . Intravenous injection in man of delta-9-tetrahydrocannabinol and 11-OH-delta-9-tetrahydro-cannabinol. . Science , 177 ( 49 ) : 633 – 5 .
   PubMedGoogle Scholar
• Perez-Reyes , M. , Burstein , S. H. , White , W. R. , McDonald , S. A. and Hicks , R. E. 1991 . Antagonism of marihuana effects by indomethacin in humans. . Life Sci , 48 ( 6 ) : 507 – 15 .
   PubMed Web of Science ®Google Scholar
• Pertwee , R. 1992 . “ In vivo interactions between pschotropic cannabinoids and other drugs involving central and peripheral neurochemical mediators. In ” . In Marijuana/Cannabinoids: neurobiology and neurophysiology Edited by: Myrphy , L. and Bartke , A. 165 – 218 . Boca Raton, FL : CRC Press .
   Google Scholar
• Pertwee , R. G. 1997 . Pharmacology of cannabinoid CB1 and CB2 receptors. . Pharmacol Ther , 74 ( 2 ) : 129 – 80 .
   PubMed Web of Science ®Google Scholar
• Pertwee , R. G. 1999a . Evidence for the presence of CB1 cannabinoid receptors on peripheral neurones and for the existence of neuronal non-CB1 cannabinoid receptors. . Life Sci , 65 : 597 – 605 .
   PubMed Web of Science ®Google Scholar
• Pertwee , R. G. 1999b . Pharmacology of cannabinoid receptor ligands. . Curr Med Chem , 6 : 635 – 64 .
   PubMed Web of Science ®Google Scholar
• Pertwee , R. G. 2002 . “ Sites and Mechanisms of Action. In ” . In Cannabis and cannabinoids. Pharmacology, toxicology, and therapeutic potential Edited by: Grotenhermen , F. and Russo , E. 73 – 88 . New York : The Haworth Press .
   Google Scholar
• Petitet , F. , Jeantaud , B. , Reibaud , M. , Imperato , A. and Dubroeucq , M. C. 1998 . Complex pharmacology of natural cannabinoids: evidence for partial agonist activity of δ9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors. . Life Sci , 63 ( 1 ) PL1–6
   PubMed Web of Science ®Google Scholar
• Petro , D. J. 1980 . Marihuana as a therapeutic agent for muscle spasm or spasticity. . Psychosomatics , 21 ( 1 ) : 81 85
   PubMed Web of Science ®Google Scholar
• Petro , D. J. and Ellenberger , C. Jr. 1981 . Treatment of human spasticity with delta 9-tetrahydrocannabinol. . J Clin Pharmacol , 21 ( 8–9 Suppl ) 413S-6S
   PubMedGoogle Scholar
• Plasse , T. F. , Gorter , R. W. , Krasnow , S. H. , Lane , M. , Shepard , K. V. and Wadleigh , R. G. 1991 . Recent clinical experience with dronabinol. . Pharmacol Biochem Behav , 40 ( 3 ) : 695 – 700 .
   PubMed Web of Science ®Google Scholar
• Pope , H. G. Jr. , Gruber , A. J. , Hudson , J. I. , Huestis , M. A. and Yurgelun-Todd , D. 2001 . Neuropsychological performance in long-term cannabis users. . Arch Gen Psychiatry , 58 ( 10 ) : 909 – 15 .
   PubMed Web of Science ®Google Scholar
• Pope , H. G. , Gruber , A. J. , Hudson , J. I. , Cohane , G. , Huestis , M. A. and Yurgelun-Todd , D. 2003 . Early-onset cannabis use and cognitive deficits: what is the nature of the association? . Drug Alcohol Depend , 69 ( 3 ) : 303 – 10 .
   PubMed Web of Science ®Google Scholar
• Pope , H. J. 2002 . Cannabis, Cognition, and Residual Confounding. . JAMA , 287 ( 9 ) : 1172 – 4 .
   PubMed Web of Science ®Google Scholar
• Porter , A. C. , Sauer , J. M. , Knierman , M. D. , Becker , G. W. , Berna , M. J. , Bao , J. , Nomikos , G. G. , Carter , P. , Bymaster , F. P. , Leese , A. B. and Felder , C. C. 2002 . Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. . J Pharmacol Exp Ther , 301 ( 3 ) : 1020 – 4 .
   PubMed Web of Science ®Google Scholar
• Pryor , G. T. , Husain , S. and Mitoma , C. 1976 . Acute and subacute interactions between delta-9-tetrahydrocannabinol and other drugs in the rat. . Ann N Y Acad Sci , 281 : 171 – 89 .
   PubMedGoogle Scholar
• Racz , I. , Bilkei-Gorzo , A. , Toth , Z. E. , Michel , K. , Palkovits , M. and Zimmer , A. 2003 . A critical role for the cannabinoid CB1 receptors in alcohol dependence and stress-stimulated ethanol drinking. . J Neurosci , 23 ( 6 ) : 2453 – 8 .
   PubMed Web of Science ®Google Scholar
• Ralevic , V. and Kendall , D. A. 2001 . Cannabinoid inhibition of capsaicin-sensitive sensory neurotransmission in the rat mesenteric arterial bed. . Eur J Pharmacol , 418 ( 1–2 ) : 117 – 25 .
   PubMedGoogle Scholar
• Ralevic , V. and Kendall , D. A. 2002 . Cannabinoids inhibit pre- and postjunctionally sympathetic neurotransmission in rat mesenteric arteries. . Eur J Pharmacol , 444 ( 3 ) : 171 – 81 .
   PubMed Web of Science ®Google Scholar
• Recht , L. D. , Salmonsen , R. , Rosetti , R. , Jang , T. , Pipia , G. , Kubiatowski , T. , Karim , P. , Ross , A. H. , Zurier , R. , Litofsky , N. S. and Burstein , S. 2001 . Antitumor effects of ajulemic acid (CT3), a synthetic non-psychoactive cannabinoid. . Biochem Pharmacol , 62 ( 6 ) : 755 – 63 .
   PubMed Web of Science ®Google Scholar
• Romero , J. , Garcia-Palomero , E. , Castro , J. G. , Garcia-Gil , L. , Ramos , J. A. and Fernandez-Ruiz , J. J. 1997 . Effects of chronic exposure to δ9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions. . Brain Res Mol Brain Res , 46 ( 1–2 ) : 100 – 8 .
   PubMedGoogle Scholar
• Roques , B. 1998 . Problemes posées par la dangerosité des drogues. Rapport du professeur Bernhard Roques au Secrétaire d'Etat à la Santé. Paris
   Google Scholar
• Rubino , T. , Vigano , D. , Costa , B. , Colleoni , M. and Parolaro , D. 2000a . Loss of cannabinoid-stimulated guanosine 5'-O-(3-[(35)S]Thiotriphosphate) binding without receptor down-regulation in brain regions of anandamide-tolerant rats. . J Neurochem , 75 ( 6 ) : 2478 – 84 .
   PubMed Web of Science ®Google Scholar
• Rubino , T. , Vigano , D. , Massi , P. and Parolaro , D. 2000b . Changes in the cannabinoid receptor binding, G protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the synthetic cannabinoid compound CP55,940. . J Neurochem , 75 ( 5 ) : 2080 – 6 .
   PubMed Web of Science ®Google Scholar
• Russo , E. , Mathre , M. L. , Byrne , A. , Velin , R. , Bach , P. J. , Sanchez-Ramos , J. and Kirlin , K. A. 2002 . Chronic cannabis use in the compassionate investigational new drug program: An examination of benefits and adverse effects of legal medical cannabis. . J Cannabis Ther , 2 ( 1 ) : 3 – 57 .
   Google Scholar
• Sallan , S. E. , Cronin , C. , Zelen , M. and Zinberg , N. E. 1980 . Antiemetics in patients receiving chemotherapy for cancer: a randomized comparison of delta-9-tetrahy-drocannabinol and prochlorperazine. . N Engl J Med , 302 ( 3 ) : 135 – 8 .
   PubMedGoogle Scholar
• Sanchez , C. , de Ceballos , M. L. , del Pulgar , T. G. , Rueda , D. , Corbacho , C. , Velasco , G. , Galve-Roperh , I. , Huffman , J. W. , Ramon y Cajal , S. and Guzman , M. 2001 . Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor. . Cancer Res , 61 ( 15 ) : 5784 – 9 .
   PubMed Web of Science ®Google Scholar
• Sandyk , R. and Awerbuch , G. 1998 . Marijuana and Tourette's syndrome. . J Clin Psychopharmacol , 8 : 844
   Google Scholar
• Sañudo-Peña , M. C. , Tsou , K. and Walker , J. M. 1999 . Motor actions of cannabinoids in the basal ganglia output nuclei. . Life Sci , 65 : 703 – 13 .
   PubMed Web of Science ®Google Scholar
• Schnelle , M. , Grotenhermen , F. , Reif , M. and Gorter , R. W. 1999 . Ergebnisse einer standardisierten Umfrage zur medizinischen Verwendung von Cannabisprodukten im deutschen Sprachraum, [Results of a standardized survey on the medical use of cannabis products in the German-speaking area]. (Suppl 3) 28–36. . Forsch Komplementarmed , : 28 – 36 . [Res Complementary Med] (Suppl 3)
   PubMedGoogle Scholar
• Schweitzer , P. 2000 . Cannabinoids decrease the K+ M-current in hippocampal CA1 neurons. . J Neurosci , 20 : 51 – 8 .
   PubMedGoogle Scholar
• Shook , J. E. and Burks , T. F. 1989 . Psychoactive cannabinoids reduce gastrointestinal propulsion and motility in rodents. . J Pharmacol Exp Ther , 249 ( 2 ) : 444 – 9 .
   PubMed Web of Science ®Google Scholar
• Showalter , V. M. , Compton , D. R. , Martin , B. R. and Abood , M. E. 1996 . Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands. . J Pharmacol Exp Ther , 278 ( 3 ) : 989 – 99 .
   PubMed Web of Science ®Google Scholar
• Siegling , A. , Hofmann , H. A. , Denzer , D. , Mauler , F. and De Vry , J. 2001 . Cannabinoid CB(1) receptor upregulation in a rat model of chronic neuropathic pain. . Eur J Pharmacol , 415 ( 1 ) R5-R7
   PubMed Web of Science ®Google Scholar
• Sieradzan , K. A. , Fox , S. H. , Hill , M. , Dick , J. P. , Crossman , A. R. and Brotchie , J. M. 2001 . Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: a pilot study. . Neurology , 57 ( 11 ) : 2108 – 11 .
   PubMed Web of Science ®Google Scholar
• Slikker , W. Jr. , Paule , M. G. , Ali , S. F. , Scallet , A. C. and Bailey , J. R. 1992 . “ Behavioral, neurochemical and neurhistochemical effects of chronic marijuana smoke exposure in the nonhuman primate. In ” . In Marijuana/Cannabinoids: neurobiology and neurophysiology Edited by: Myrphy , L. and Bartke , A. 219 – 73 . Boca Raton, FL : CRC Press .
   Google Scholar
• Smith , C. G. , Almirez , R. G. , Berenberg , J. and Asch , R. H. 1983 . Tolerance develops to the disruptive effects of delta 9-tetrahydrocannabinol on primate menstrual cycle. . Science , 219 ( 4591 ) : 1453 – 5 .
   PubMed Web of Science ®Google Scholar
• Soderpalm , A. H. , Schuster , A. and de Wit , H. 2001 . Antiemetic efficacy of smoked marijuana: subjective and behavioral effects on nausea induced by syrup of ipecac. . Pharmacol Biochem Behav , 69 ( 3–4 ) : 343 – 50 .
   PubMedGoogle Scholar
• Sofia , R. D. , Nalepa , S. D. , Harakal , J. J. and Vassar , V. B. 1973 . Anti-edema and analgesic properties of δ9-tetrahydrocannabinol (THC). . J Pharmacol Exp Ther , 186 ( 3 ) : 646 – 55 .
   PubMedGoogle Scholar
• Solowij , N. and Grenyer , B. F.S. 2002b . “ Long term effects of cannabis on psyche and cognition. In ” . In Cannabis and cannabinoids. Pharmacology, toxicology, and therapeutic potential Edited by: Grotenhermen , F. and Russo , E. 299 – 312 . New York : The Haworth Press .
   Google Scholar
• Solowij , N. , Stephens , R. S. , Roffman , R. A. , Babor , T. , Kadden , R. , Miller , M. , Christiansen , K. , McRee , B. and Vendetti , J. 2002 . Cognitive Functioning of Longterm Heavy Cannabis Users Seeking Treatment. . JAMA , 287 ( 9 ) : 1123 – 31 .
   PubMed Web of Science ®Google Scholar
• Stefanis , C. 1978 . Biological aspects of cannabis use. . NIDA Res Monogr , 19 : 149 – 78 .
   Google Scholar
• Stockings , G. T. 1947 . A new euphoriant for depressive mental states. . BMJ , 1 : 918 – 22 .
   PubMed Web of Science ®Google Scholar
• Sugiura , T. , Kondo , S. , Sukagawa , A. , Nakane , S. , Shinoda , A. , Itoh , K. , Yamashita , A. and Waku , K. 1995 . 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. . Biochem Biophys Res Commun , 215 ( 1 ) : 89 – 97 .
   PubMed Web of Science ®Google Scholar
• Sulcova , E. , Mechoulam , R. and Fride , E. 1998 . Biphasic effects of anandamide. . Pharmacol Biochem Behav , 59 ( 2 ) : 347 – 52 .
   PubMed Web of Science ®Google Scholar
• Sutin , K. M. and Nahas , G. G. 1999 . “ Physiological and pharmacological interations of marihuana (δ9-THC) with drugs and anesthetics. In ” . In Marihuana and Medicine Edited by: Nahas , G. , Sutin , K. M. , Harvey , D. J. and Agurell , S. 253 – 71 . Totowa, NJ : Humana Press .
   Google Scholar
• Szabo , B. , Nordheim , U. and Niederhoffer , N. 2001 . Effects of cannabinoids on sympathetic and parasympathetic neuroeffector transmission in the rabbit heart. . J Pharmacol Exp Ther , 297 : 819 – 26 .
   PubMedGoogle Scholar
• Tahir , S. K. , Trogadis , J. E. , Stevens , J. K. and Zimmerman , A. M. 1992 . Cytoskeletal organization following cannabinoid treatment in undifferentiated and differentiated PC12 cells. . Biochem Cell Biol , 70 ( 10–11 ) : 1159 – 73 .
   PubMedGoogle Scholar
• Tanda , G. , Pontieri , F. E. and Di Chiara , G. 1997 . Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. . Science , 276 ( 5321 ) : 2048 – 50 .
   PubMed Web of Science ®Google Scholar
• Tashkin , D. P. , Shapiro , B. J. and Frank , I. M. 1974 . Acute effects of smoked marijuana and oral δ9-tetrahydrocannabinol on specific airway conductance in asthmatic subjects. . Am Rev Respir Dis , 109 ( 4 ) : 420 – 8 .
   PubMedGoogle Scholar
• Tashkin , D. P. , Levisman , J. A. , Abbasi , A. S. , Shapiro , B. J. and Ellis , N. M. 1977 . Short-term effects of smoked marihuana on left ventricular function in man. . Chest , 72 ( 1 ) : 20 – 6 .
   PubMed Web of Science ®Google Scholar
• Terranova , J.-P. , Storme , J.-J. , Lafon , N. , Perio , A. , Rinaldi-Carmona , G. Le Fur and Soubrie , P. 1996 . Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716. . Psychopharmacology , 126 : 165 – 72 .
   PubMed Web of Science ®Google Scholar
• Thompson , G. R. , Rosenkrantz , H. , Schaeppi , U. H. and Braude , M. C. 1973 . Comparison of acute oral toxicity of cannabinoids in rats, dogs and monkeys. . Toxicol Appl Pharmacol , 25 ( 3 ) : 363 – 72 .
   PubMed Web of Science ®Google Scholar
• Thompson , L. J. and Proctor , R. C. 1953 . The use of pyrahexyl in the treatment of alcoholic and drug withdrawal conditions. . N Carolina Med J , 14 : 520 – 3 .
   PubMedGoogle Scholar
• Titishov , N. , Mechoulam , R. and Zimmerman , A. M. 1989 . Stereospecific effects of (-)- and (+)-7-hydroxy-delta-6-tetrahydrocannabinol-dimethylheptyl on the immune system of mice. . Pharmacology , 39 ( 6 ) : 337 – 49 .
   PubMed Web of Science ®Google Scholar
• Toyota , M. , Shimamura , T. , Ishii , H. , Renner , M. , Braggins , J. and Asakawa , Y. 2002 . New bibenzyl cannabinoid from the New Zealand liverwort Radula marginata. . Chem Pharm Bull (Tokyo) , 50 ( 10 ) : 1390 – 2 .
   PubMed Web of Science ®Google Scholar
• Ungerleider , J. T. , Andyrsiak , T. , Fairbanks , L. , Ellison , G. W. and Myers , L. W. 1987 . Delta-9-THC in the treatment of spasticity associated with multiple sclerosis. . Adv Alcohol Subst Abuse , 7 ( 1 ) : 39 – 50 .
   PubMedGoogle Scholar
• Vacca , G. , Serra , S. , Brunetti , G. , Carai , M. A. , Gessa , GL. and Colombo , G. 2002 . Boosting effect of morphine on alcohol drinking is suppressed not only by naloxone but also by the cannabinoid CB1 receptor antagonist, SR 141716. . Eur J Pharmacol , 445 ( 1–2 ) : 55 – 9 .
   PubMedGoogle Scholar
• Van der Stelt , M. , Veldhuis , W. B. , Bar , P. R. , Veldink , G. A. , Vliegenthart , J. F. and Nicolay , K. 2001 . Neuroprotection by delta-9-tetrahydrocannabinol, the main active compound in marijuana, against ouabain-induced in vivo excitotoxicity. . JNeurosci , 21 ( 17 ) : 6475 – 9 .
   PubMed Web of Science ®Google Scholar
• Van Klingeren , B. and Ten Ham , M. 1976 . Antibacterial activity of delta-9-tetrahydrocannabinol and cannabidiol. . Antonie Van Leeuwenhoek , 42 ( 1–2 ) : 9 – 12 .
   PubMedGoogle Scholar
• Volicer , L. , Stelly , M. , Morris , J. , McLaughlin , J. and Volicer , B. J. 1997 . Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer's disease. . Int J Geriatr Psychiatry , 12 ( 9 ) : 913 – 9 .
   PubMed Web of Science ®Google Scholar
• Vollmer , R. R. , Cavero , I. , Ertel , R. J. , Solomon , T. A. and Buckley , J. P. 1974 . Role of the central nervous system in the hypotension and bradycardia induced by (-)-δ9-trans-tetrahydrocannabinol. . J Pharm Pharmacol , 26 : 186 – 92 .
   PubMed Web of Science ®Google Scholar
• Wachtel , S. R. and de Wit , H. 2000 . Naltrexone does not block the subjective effects of oral δ9-tetrahydrocannabinol in humans. . Drug Alcohol Depend , 59 ( 3 ) : 251 – 60 .
   PubMed Web of Science ®Google Scholar
• Wachtel , S. R. , ElSohly , M. A. , Ross , S. A. , Ambre , J. and De Wit , H. 2002 . Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol and marijuana in humans. . Psychopharmacology , 161 ( 4 ) : 331 – 9 .
   PubMed Web of Science ®Google Scholar
• Wachtel , S. R. , ElSohly , M. A. , Ross , S. A. , Ambre , J. and de Wit , H. 2002 . Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol and marijuana in humans. . Psychopharmacology (Berl) , 161 ( 4 ) : 331 – 9 .
   PubMed Web of Science ®Google Scholar
• Wade , D. T. , Robson , P. , House , H. , Makela , P. and Aram , J. 2003 . A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms. . Clin Rehabil , 17 : 18 – 26 .
   Web of Science ®Google Scholar
• Wagner , J. A. , Hu , K. , Karcher , J. , Bauersachs , J. , Schafer , A. , Laser , M. , Han , H. and Ertl , G. 2003 . CB(1) cannabinoid receptor antagonism promotes remodeling and cannabinoid treatment prevents endothelial dysfunction and hypotension in rats with myocardial infarction. . Br J Pharmacol , 138 ( 7 ) : 1251 – 8 .
   PubMed Web of Science ®Google Scholar
• Wagner , J. A. , Varga , K. and Kunos , G. 1998 . Cardiovascular actions of cannabinoids and their generation during shock. . J Mol Med , 76 ( 12 ) : 824 – 36 .
   PubMed Web of Science ®Google Scholar
• Wagner , J. A. , Jarai , Z. , Batkai , S. and Kunos , G. 2001 . Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors. . Eur J Pharmacol , 423 ( 2–3 ) : 203 – 10 .
   PubMed Web of Science ®Google Scholar
• Walker , J. M. , Huang , S. M. , Strangman , N. M. , Tsou , K. and Sanudo-Pena , M. C. 1999 . Pain modulation by release of the endogenous cannabinoid anandamide. . Proc Natl Acad Sci U S A , 96 ( 21 ) : 12198 – 203 .
   PubMed Web of Science ®Google Scholar
• Wall , M. E. , Brine , D. R. and Perez-Reyes , M. 1976 . “ Metabolism of cannabinoids in man. In ” . In Pharmacology of Marihuana Edited by: Braude , M. C. and Szara , S. 93 – 113 . New York : Raven Press .
   Google Scholar
• Welch , S. P. and Eads , M. 1999 . Synergistic interactions of endogenous opioids and cannabinoid systems. . Brain Res , 848 ( 1–2 ) : 183 – 90 .
   PubMed Web of Science ®Google Scholar
• Wiley , J. L. and Martin , B. R. 2002 . Cannabinoid pharmacology: implications for additional cannabinoid receptor subtypes. . Chem Phys Lipids , 121 ( 1–2 ) : 57 – 63 .
   PubMed Web of Science ®Google Scholar
• Williams , C. M. and Kirkham , T. C. 1999 . Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors. . Psychopharmacology , 143 ( 3 ) : 315 – 7 .
   PubMed Web of Science ®Google Scholar
• Williams , C. M. and Kirkham , T. C. 2002 . Observational analysis of feeding induced by Delta(9)-THC and anandamide. . Physiol Behav , 76 ( 2 ) : 241 – 50 .
   PubMed Web of Science ®Google Scholar
• Williams , S. J. , Hartley , J. P. and Graham , J. D. 1976 . Bronchodilator effect of delta1-tetrahydrocannabinol administered by aerosol of asthmatic patients. . Thorax , 31 ( 6 ) : 720 – 3 .
   PubMed Web of Science ®Google Scholar
• Yuan , M. , Kiertscher , S. M. , Cheng , Q. , Zoumalan , R. , Tashkin , D. P. and Roth , M. D. 2002 . Delta 9-Tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells. . J Neuroimmunol , 133 ( 1–2 ) : 124 – 31 .
   PubMedGoogle Scholar
• Zuardi , A. W. , Guimarães , F. S. , Guimarães , V. M.C. and Del Bel , E. A. 2002 . “ Cannabidiol: Possible therapeutic application. In ” . In Cannabis and cannabinoids. Pharmacology, toxicology, and therapeutic potential Edited by: Grotenhermen , F. and Russo , E. 359 – 70 . New York : The Haworth Press .
   Google Scholar
• Zuardi , A. W. , Shirakawa , I. , Finkelfarb , E. and Karniol , I. G. 1982 . Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects. . Psychopharmacology , 76 ( 3 ) : 245 – 50 .
   PubMed Web of Science ®Google Scholar
• Zullino , D. F. , Delessert , D. , Eap , C. B. , Preisig , M. and Baumann , P. 2002 . Tobacco and cannabis smoking cessation can lead to intoxication with clozapine or olanzapine. . Int Clin Psychopharmacol , 17 ( 3 ) : 141 – 3 .
   PubMed Web of Science ®Google Scholar